MaxCyte, Inc.
MXCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -19.7% | -18.1% | 19.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 92.4% | 82.1% | 85.6% | 73.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -169.4% | -152% | -106% | -130.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -181.8% | -145.3% | -98.8% | -121.9% |
| EPS Diluted | -0.12 | -0.12 | -0.1 | -0.1 |
| % Growth | 0% | -20% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |